Skip to main content
SpringerLink
Log in

Uveal Melanoma: Epidemiologic Aspects

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

Abstract

Melanomas of the ocular and adnexal structures comprise approximately 5 % of all melanomas. The majority (95 %) of ocular melanomas are uveal in origin, whereas primary conjunctival and orbital melanoma are very rare. Uveal melanoma is the most common primary intraocular malignant tumor. In this chapter, the incidence of uveal melanoma and various etiological factors implicated in the pathogenesis of uveal melanoma are briefly outlined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664–78.

    Article  CAS  PubMed  Google Scholar 

  2. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology. 2003;110(5):956–61.

    Article  PubMed  Google Scholar 

  3. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118(9):1881–5.

    Article  PubMed  Google Scholar 

  4. Strickland D, Lee JA. Melanomas of eye: stability of rates. Am J Epidemiol. 1981;113(6):700–2.

    CAS  PubMed  Google Scholar 

  5. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129–31.

    Article  PubMed  Google Scholar 

  6. Scotto J, Fraumeni Jr JF, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst. 1976;56(3):489–91.

    CAS  PubMed  Google Scholar 

  7. Reis L, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973–2000. Bethesda: National Cancer Institute; 2003.

    Google Scholar 

  8. Barzilai DA, Koroukian SM, Neuhauser D, et al. The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States). Cancer Causes Control. 2004;15(2):179–84.

    Article  PubMed  Google Scholar 

  9. McLaughlin CC, Wu XC, Jemal A, et al. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103(5):1000–7.

    Article  PubMed  Google Scholar 

  10. Stang A, Parkin DM, Ferlay J, Jockel KH. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int J Cancer. 2005;114(1):114–23.

    Article  CAS  PubMed  Google Scholar 

  11. Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am. 2005;18(1):75–84, viii.

    Article  PubMed  Google Scholar 

  12. Keenan TD, Yeates D, Goldacre MJ. Uveal melanoma in England: trends over time and geographical variation. Br J Ophthalmol. 2012;96(11):1415–9.

    Article  PubMed  Google Scholar 

  13. Vajdic CM, Kricker A, Giblin M, et al. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer. 2002;101(2):175–82.

    Article  CAS  PubMed  Google Scholar 

  14. Michalova K, Clemett R, Dempster A, et al. Iris melanomas: are they more frequent in New Zealand? Br J Ophthalmol. 2001;85(1):4–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Bergman L, Seregard S, Nilsson B, et al. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2002;43(8):2579–83.

    PubMed  Google Scholar 

  16. Egan KM, Seddon JM, Glynn RJ, et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32(4):239–51.

    Article  CAS  PubMed  Google Scholar 

  17. Hu DN, Yu GP, McCormick SA, et al. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol. 2005;140(4):612–7.

    PubMed  Google Scholar 

  18. Kaneko A. [Malignant ophthalmic tumors]. Nippon Rinsho. 1993;51(Suppl):1013–20.

    PubMed  Google Scholar 

  19. Naumann G, Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body. Arch Ophthalmol. 1966;76(6):784–96.

    Article  CAS  PubMed  Google Scholar 

  20. Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. II. Relationship of uveal nevi to malignant melanomas. Cancer. 1967;20(4):493–507.

    Article  CAS  PubMed  Google Scholar 

  21. Sahel JA, Pesavento R, Frederick Jr AR, Albert DM. Melanoma arising de novo over a 16-month period. Arch Ophthalmol. 1988;106(3):381–5.

    Article  CAS  PubMed  Google Scholar 

  22. Albert DM, Robinson NL, Fulton AB, et al. Epidemiological investigation of increased incidence of choroidal melanoma in a single population of chemical workers. Int Ophthalmol Clin. 1980;20(2):71–92.

    CAS  PubMed  Google Scholar 

  23. Singh AD, Kalyani P, Topham B. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005;112(10):1784–9.

    Article  PubMed  Google Scholar 

  24. Ponder BAJ. Inherited cancer syndromes. In: Carney D, Sikora K, editors. Genes and cancer. New York: John Wiley and Sons; 1990.

    Google Scholar 

  25. Singh AD, Damato B, Howard P, Harbour JW. Uveal melanoma: genetic aspects. Ophthalmol Clin North Am. 2005;18(1):85–97, viii.

    Article  PubMed  Google Scholar 

  26. Jay M, McCartney AC. Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol. 1993;37(6):457–62.

    Article  CAS  PubMed  Google Scholar 

  27. Singh AD, Donoso LA, Jackson L, et al. Familial uveal melanoma: absence of constitutional cytogenic abnormalities in 14 cases [comment]. Arch Ophthalmol. 1996;114(4):502–3.

    Article  CAS  PubMed  Google Scholar 

  28. Singh AD, Shields CL, Shields JA, Sato T. Uveal melanoma in young patients. Arch Ophthalmol. 2000;118(7):918–23.

    CAS  PubMed  Google Scholar 

  29. Barr CC, McLean IW, Zimmerman LE. Uveal melanoma in children and adolescents. Arch Ophthalmol. 1981;99(12):2133–6.

    Article  CAS  PubMed  Google Scholar 

  30. Greer CH. Congenital melanoma of the anterior uvea. Arch Ophthalmol. 1966;76:77–8.

    Article  CAS  PubMed  Google Scholar 

  31. Verdaguer Jr J. Prepuberal and puberal melanomas in ophthalmology. Am J Ophthalmol. 1965;60:1002–11.

    PubMed  Google Scholar 

  32. Singh AD, Shields JA, Eagle RC, et al. Iris melanoma in a ten-year-old boy with familial atypical mole-melanoma (FAM-M) syndrome. Ophthalmic Genet. 1994;15(3–4):145–9.

    Article  CAS  PubMed  Google Scholar 

  33. Shammas HF, Watzke RC. Bilateral choroidal melanomas. Case report and incidence. Arch Ophthalmol. 1977;95:617–23.

    Article  CAS  PubMed  Google Scholar 

  34. Singh AD, Shields CL, Shields JA, De Potter P. Bilateral primary uveal melanoma. Bad luck or bad genes? Ophthalmology. 1996;103(2):256–62.

    Article  CAS  PubMed  Google Scholar 

  35. Seregard S, Daunius C, Kock E, Popovic V. Two cases of primary bilateral malignant melanoma of the choroid. Br J Ophthalmol. 1988;72(4):244–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Bergman L, Nilsson B, Ragnarsson-Olding B, Seregard S. Uveal melanoma: A study on incidence of additional cancers and familial cases in the Swedish population. Invest Ophthalmol Vis Sci. 2006;47:72–7.

    Google Scholar 

  37. Honavar SG, Shields CL, Singh AD, et al. Two discrete choroidal melanomas in an eye with ocular melanocytosis. Surv Ophthalmol. 2002;47(1):36–41.

    Article  PubMed  Google Scholar 

  38. Singh AD, Rundle PA, Slater DN, et al. Paraneoplastic melanocytic proliferation: uveal and cutaneous involvement. Arch Ophthalmol. 2003;121:1637–40.

    Article  PubMed  Google Scholar 

  39. Gonder JR, Shields JA, Albert DM, et al. Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology. 1982;89(8):953–60.

    Article  CAS  PubMed  Google Scholar 

  40. Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105(1):195–8.

    Article  CAS  PubMed  Google Scholar 

  41. Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457(7229):599–602.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Gerami P, Pouryazdanparast P, Vemula S, Bastian BC. Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. Am J Dermatopathol. 2010;32(3):301–5.

    PubMed  Google Scholar 

  43. Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20(4):617–28.

    Article  PubMed  Google Scholar 

  44. Clark Jr WH, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: ‘The B-K Mole syndrome’. Arch Dermatol. 1978;114(5):732–8.

    Article  PubMed  Google Scholar 

  45. NIH. NIH consensus conference. Diagnosis and treatment of early melanoma. JAMA. 1992;268(10):1314–9.

    Article  Google Scholar 

  46. Singh AD, Shields CL, Shields JA, et al. Uveal melanoma and familial atypical mole and melanoma (FAM-M) syndrome. Ophthalmic Genet. 1995;16(2):53–61.

    Article  CAS  PubMed  Google Scholar 

  47. Bataille V, Sasieni P, Cuzick J, et al. Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer. 1995;60(5):622–6.

    Article  CAS  PubMed  Google Scholar 

  48. van Hees CL, de Boer A, Jager MJ, et al. Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Dermatol. 1994;103(2):202–5.

    Article  PubMed  Google Scholar 

  49. Seregard S, af Trampe E, Mansson-Brahme E, et al. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study. Ophthalmology. 1995;102(10):1524–9.

    Article  CAS  PubMed  Google Scholar 

  50. Greene MH, Sanders RJ, Chu FC, et al. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol. 1983;96(2):238–45.

    CAS  PubMed  Google Scholar 

  51. de Snoo FA, Bergman W, Gruis NA. Familial melanoma: a complex disorder leading to controversy on DNA testing. Fam Cancer. 2003;2(2):109–16.

    Article  PubMed  Google Scholar 

  52. Ohta M, Nagai H, Shimizu M, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res. 1994;54(20):5269–72.

    CAS  PubMed  Google Scholar 

  53. Hurst EA, Harbour JW, Cornelius LA. Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol. 2003;139(8):1067–73.

    Article  PubMed  Google Scholar 

  54. Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Njauw CN, Kim I, Piris A, et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012;7(4):e35295.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Wiesner T, Obenauf AC, Murali R, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011;43(10):1018–21.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Wiesner T, Murali R, Fried I, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36(6):818–30.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Yoshikawa Y, Sato A, Tsujimura T, et al. Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci. 2012;103(5):868–74.

    Article  CAS  PubMed  Google Scholar 

  59. Abdel-Rahman MH, Cebulla CM, Verma V, et al. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Exp Eye Res. 2012;100:26–31.

    Article  CAS  PubMed  Google Scholar 

  60. Honavar SG, Singh AD, Shields CL, et al. Iris melanoma in a patient with neurofibromatosis. Surv Ophthalmol. 2000;45(3):231–6.

    Article  CAS  PubMed  Google Scholar 

  61. Foster WJ, Fuller CE, Perry A, Harbour JW. Status of the NF1 tumor suppressor locus in uveal melanoma. Arch Ophthalmol. 2003;121(9):1311–5.

    Article  CAS  PubMed  Google Scholar 

  62. Li FP, Fraumeni JF, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988;48:5358–62.

    CAS  PubMed  Google Scholar 

  63. Turner BJ, Siatkowski RM, Augsburger JJ, et al. Other cancers in uveal melanoma patients and their families. Am J Ophthalmol. 1989;107(6):601–8.

    CAS  PubMed  Google Scholar 

  64. Lischko AM, Seddon JM, Gragoudas ES, et al. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 1989;96(12):1716–21.

    Article  CAS  PubMed  Google Scholar 

  65. Holly EA, Aston DA, Ahn DK, et al. No excess prior cancer in patients with uveal melanoma. Ophthalmology. 1991;98(5):608–11.

    Article  CAS  PubMed  Google Scholar 

  66. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25. Arch Ophthalmol. 2005;123(5):601–4.

    Article  PubMed  Google Scholar 

  67. Singh AD, Rennie IG, Seregard S, et al. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol. 2004;49(4):419–28.

    Article  PubMed  Google Scholar 

  68. Seddon JM, Gragoudas ES, Glynn RJ, et al. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990;108(9):1274–80.

    Article  CAS  PubMed  Google Scholar 

  69. Holly EA, Aston DA, Ahn DK, Smith AH. Intraocular melanoma linked to occupations and chemical exposures. Epidemiology. 1996;7(1):55–61.

    Article  CAS  PubMed  Google Scholar 

  70. Ajani UA, Seddon JM, Hsieh CC, et al. Occupation and risk of uveal melanoma. An exploratory study. Cancer. 1992;70(12):2891–900.

    Article  CAS  PubMed  Google Scholar 

  71. Behrens T, Lynge E, Cree I, et al. Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma. Occup Environ Med. 2010;67(11):751–9.

    Article  PubMed  Google Scholar 

  72. Behrens T, Lynge E, Cree I, et al. Occupational exposure to endocrine-disrupting chemicals and the risk of uveal melanoma. Scand J Work Environ Health. 2012;38(5):476–83.

    Article  PubMed  Google Scholar 

  73. Behrens T, Lynge E, Cree I, et al. Pesticide exposure in farming and forestry and the risk of uveal melanoma. Cancer Causes Control. 2012;23(1):141–51.

    Article  PubMed  Google Scholar 

  74. Behrens T, Kaerlev L, Cree I, et al. Hormonal exposures and the risk of uveal melanoma. Cancer Causes Control. 2010;21(10):1625–34.

    Article  PubMed  Google Scholar 

  75. Stang A, Schmidt-Pokrzywniak A, Lash TL, et al. Mobile phone use and risk of uveal melanoma: results of the risk factors for uveal melanoma case-control study. J Natl Cancer Inst. 2009;101(2):120–3.

    Article  PubMed Central  PubMed  Google Scholar 

  76. Mulla ZD, Margo CE. Season of birth and the risk of uveal melanoma. Ophthalmic Epidemiol. 2009;16(2):74–7.

    Article  PubMed  Google Scholar 

  77. Guenel P, Laforest L, Cyr D, et al. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control. 2001;12(5):451–9.

    Article  CAS  PubMed  Google Scholar 

  78. Vidal JL, Bacin F, Albuisson E, et al. [“Melanoma 92”. epidemiological study of uveal melanoma in France]. J Fr Ophtalmol. 1995;18(8–9):520–8.

    CAS  PubMed  Google Scholar 

  79. Tucker MA, Shields JA, Hartge P, et al. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med. 1985;313(13):789–92.

    Article  CAS  PubMed  Google Scholar 

  80. Ge YR, Tian N, Lu Y, et al. Occupational cooking and risk of uveal melanoma: a meta- analysis. Asian Pac J Cancer Prev. 2012;13(10):4927–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard School of Public Health, Boston, MA, USA

    Nakul Singh MS

  2. St Erik’s Eye Hospital, Karolinska University, Stockholm, Sweden

    Louise Bergman MD & Stefan Seregard MD, PhD

  3. Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Arun D. Singh MD

Authors
  1. Nakul Singh MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louise Bergman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Seregard MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arun D. Singh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arun D. Singh MD .

Editor information

Editors and Affiliations

  1. Ocular Oncology Service, Departments of Ophthalmology and Radiation Oncology, University of California, San Francisco, San Francisco, California, USA

    Bertil Damato

  2. Dept. of Ophthalmic Oncology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Arun D. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Singh, N., Bergman, L., Seregard, S., Singh, A.D. (2014). Uveal Melanoma: Epidemiologic Aspects. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54255-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54255-8_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54254-1

  • Online ISBN: 978-3-642-54255-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation